WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000027879) PLATELET-DERIVED GROWTH FACTOR D, DNA CODING THEREFOR, AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/027879    International Application No.:    PCT/US1999/026462
Publication Date: 18.05.2000 International Filing Date: 10.11.1999
Chapter 2 Demand Filed:    09.06.2000    
IPC:
A61K 38/00 (2006.01), C07K 14/49 (2006.01)
Applicants: LUDWIG INSTITUTE FOR CANCER RESEARCH [US/US]; 605 Third Avenue New York, NY 10158 (US).
LICENTIA LTD. [FI/FI]; Erottajankatu 19 B 5 00130 Helsinki (FI)
Inventors: ERIKSSON, Ulf; (SE).
AASE, Karin; (SE).
PONTEN, Annica; (SE).
LI, Xuri; (SE).
UUTELA, Marko; (FI).
ALITALO, Kari; (FI).
OESTMAN, Arne; (SE).
HELDIN, Carl-Henrik; (SE)
Agent: EVANS, Joseph, D.; Evenson, McKeown, Edwards & Lenahan, P.L.L.C. Suite 700 1200 G Street, N.W. Washington, DC 20005 (US)
Priority Data:
60/107,852 10.11.1998 US
60/113,997 28.12.1998 US
60/150,604 26.08.1999 US
60/157,108 04.10.1999 US
60/157,756 05.10.1999 US
Title (EN) PLATELET-DERIVED GROWTH FACTOR D, DNA CODING THEREFOR, AND USES THEREOF
(FR) FACTEUR DE CROISSANCE D D'ORIGINE PLAQUETTAIRE, L'ADN CODANT POUR CELUI-CI, ET SES UTILISATIONS
Abstract: front page image
(EN)PDGF-D, a new member of the PDGF/VEGF family of growth factors, is described, as well as the nucleotide sequence encoding it, methods for producing it, antibodies and other antagonists to it, transfected and transformed host cells expressing it, pharmaceutical compositions containing it, and uses thereof in medical and diagnostic applications.
(FR)L'invention concerne PDGF-D, un nouveau membre de la famille PDGF/VEGF des facteurs de croissance, ainsi que la séquence nucléotidique codant pour ce facteur PDGF-D. Cette invention concerne également des procédés de production de ce facteur, des anticorps et d'autres antagonistes de celui-ci, des cellules hôtes transfectées et transformées qui l'expriment, des compositions pharmaceutiques qui le contiennent, et enfin l'utilisation de ce facteur dans des applications médicales et diagnostiques.
Designated States: AE, AL, AU, BA, BB, BG, BR, CA, CN, CU, CZ, EE, GD, HR, HU, ID, IL, IN, IS, JP, KP, KR, LC, LK, LR, LT, LV, MG, MK, MN, MX, NO, NZ, PL, RO, SG, SI, SK, TR, TT, UA, UZ, VN, YU.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)